Inhibiting Cholesterol-Associated Protein Reduces High-Risk Blockages in Arteries
Perelman School of Medicine at the University of PennsylvaniaUsing the drug darapladib, researchers have inhibited a cholesterol-and immune system-associated protein, thereby reducing the development of heart-disease plaques that may cause death, heart attacks, and strokes in a pig model of atherosclerosis and diabetes.